China gives its first COVID-19 vaccine approval to Sinopharm
China's health authorities on Thursday approved COVID-19 vaccine from state-owned Sinopharm for general public use, making it the country's first approved shot. The rollout would begin soon at a significantly reduced cost, officials said. China has administered over 4.5 million doses to citizens using at least three different vaccines since it launched an emergency use programme in July.